KV Pharma lays off 14 workers in Florida
KV Pharmaceutical Co. notified state regulators it was laying off nine employees in Largo and five employees in Plantation.
The layoffs took place on March 6, according to a notice posted Thursday by the Agency for Workforce Innovation.
The St. Louis-based pharmaceutical company is reducing its work force by about 1,700 employees nationwide.
KV (NYSE: KVa/KVb) last month entered a consent decree with the U.S. Food and Drug Administration regarding its drug manufacturing and distribution. As part of that decree, KV agreed not to market products it manufactures, until it has satisfied requirements designed to demonstrate compliance with the FDA’s good manufacturing practices regulations, a release from the company said.
KV does not have manufacturing facilities in Florida, but laid off workers across the country as a result of the consent decree, said Michael Anderson, a spokesman for the firm car insurance quotes. He declined further comment. The workers are sales employees whose primary duties involve work outside of KV Pharmaceutical’s regular employment sites, the company said in a letter to the state agency.
KV is a specialty pharmaceutical company that develops, manufactures, markets and acquires branded and generic prescription products. It markets its branded products through its Ther-Rx Corp. subsidiary and its generic products through its ETHEX Corp. subsidiary.